(UCRH) Amundi Index Solutions - Ratings and Ratios
ESG, Corporate, Bonds
Description: UCRH Amundi Index Solutions
The Amundi Index US Corp SRI UCITS ETF DR Hedged EUR Inc is designed to mirror the performance of the Bloomberg Barclays MSCI US Corporate SRI Index, a benchmark that tracks US corporate bonds issued by companies that adhere to strict environmental, social, and governance (ESG) criteria. The funds primary objective is to minimize the tracking error between its net asset value and the indexs performance, ensuring that investors closely follow the returns of the underlying index.
By focusing on companies that meet specific ESG standards, this ETF caters to investors seeking to align their investments with sustainable and responsible practices. The Bloomberg Barclays MSCI US Corporate SRI Index is composed of bonds from US corporations that demonstrate strong ESG profiles, potentially reducing the risk associated with ESG-related controversies and enhancing long-term sustainability.
From a technical standpoint, analyzing the ETFs recent price movements and trends can provide insights into its potential future performance. The current price of 39.03 is slightly above its 20-day Simple Moving Average (SMA) of 38.93, indicating a minor positive trend. However, it is below both its 50-day SMA of 39.15 and 200-day SMA of 39.16, suggesting that the ETF is experiencing some resistance at these higher levels. The Average True Range (ATR) of 0.28, representing 0.71% of the current price, indicates relatively low volatility.
Combining technical and fundamental data, we can forecast the ETFs potential trajectory. With an Assets Under Management (AUM) of 353.24M EUR, the fund has a considerable size, which can contribute to liquidity and potentially lower trading costs. Given the current technical indicators and the overall trend in the US corporate bond market, it is plausible that the ETF may continue to consolidate around its current price levels. If the broader US corporate bond market, particularly the ESG-focused segment, experiences a positive shift due to improving ESG practices among corporations or increased investor appetite for sustainable investments, the Bloomberg Barclays MSCI US Corporate SRI Index could see an uptick, potentially driving the ETFs price higher.
Forecasting the ETFs performance involves considering both the macroeconomic environment and the specific characteristics of the underlying index. Assuming a stable to positive outlook for US corporate bonds with strong ESG profiles, and given the ETFs current technical positioning, a potential target price could be near its 52-week high of 40.21, representing a gain of approximately 3.02% from its current price. However, this forecast is contingent upon the ETF continuing to track its underlying index closely and favorable market conditions persisting.
Additional Sources for UCRH ETF
UCRH ETF Overview
Market Cap in USD | 417m |
Category | Other Bond |
TER | 0.18% |
IPO / Inception | 2021-02-23 |
UCRH ETF Ratings
Growth Rating | -15.2 |
Fundamental | - |
Dividend Rating | 67.5 |
Rel. Strength | 5.14 |
Analysts | - |
Fair Price Momentum | 38.38 EUR |
Fair Price DCF | - |
UCRH Dividends
Dividend Yield 12m | 4.01% |
Yield on Cost 5y | 3.68% |
Annual Growth 5y | 17.08% |
Payout Consistency | 98.5% |
Payout Ratio | % |
UCRH Growth Ratios
Growth Correlation 3m | 67.4% |
Growth Correlation 12m | 1.4% |
Growth Correlation 5y | -31.4% |
CAGR 5y | -1.79% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | -0.45 |
Alpha | -0.53 |
Beta | -0.029 |
Volatility | 6.08% |
Current Volume | 4.9k |
Average Volume 20d | 1.5k |
As of July 04, 2025, the stock is trading at EUR 39.75 with a total of 4,930 shares traded.
Over the past week, the price has changed by +0.22%, over one month by +1.40%, over three months by +0.63% and over the past year by +3.87%.
Neither. Based on ValueRay´s Analyses, Amundi Index Solutions is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -15.19 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UCRH is around 38.38 EUR . This means that UCRH is currently overvalued and has a potential downside of -3.45%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, UCRH Amundi Index Solutions will be worth about 41.5 in July 2026. The stock is currently trading at 39.75. This means that the stock has a potential upside of +4.28%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 41.5 | 4.3% |